- Home
- SMX vs ABVC Comparison
SMX vs ABVC Comparison
Compare SMX & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMX
- ABVC
- Stock Information
- Founded
- SMX N/A
- ABVC 2015
- Country
- SMX Ireland
- ABVC United States
- Employees
- SMX N/A
- ABVC N/A
- Industry
- SMX Industrial Machinery/Components
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- SMX Technology
- ABVC Health Care
- Exchange
- SMX Nasdaq
- ABVC Nasdaq
- Market Cap
- SMX 7.6M
- ABVC 6.5M
- IPO Year
- SMX N/A
- ABVC N/A
- Fundamental
- Price
- SMX $0.23
- ABVC $0.55
- Analyst Decision
- SMX
- ABVC
- Analyst Count
- SMX 0
- ABVC 0
- Target Price
- SMX N/A
- ABVC N/A
- AVG Volume (30 Days)
- SMX 3.8M
- ABVC 165.5K
- Earning Date
- SMX 11-29-2024
- ABVC 11-14-2024
- Dividend Yield
- SMX N/A
- ABVC N/A
- EPS Growth
- SMX N/A
- ABVC N/A
- EPS
- SMX 6.43
- ABVC N/A
- Revenue
- SMX N/A
- ABVC $509,788.00
- Revenue This Year
- SMX N/A
- ABVC N/A
- Revenue Next Year
- SMX N/A
- ABVC N/A
- P/E Ratio
- SMX $0.04
- ABVC N/A
- Revenue Growth
- SMX N/A
- ABVC N/A
- 52 Week Low
- SMX $0.20
- ABVC $0.41
- 52 Week High
- SMX $102.00
- ABVC $2.45
- Technical
- Relative Strength Index (RSI)
- SMX 23.12
- ABVC 46.18
- Support Level
- SMX $0.20
- ABVC $0.53
- Resistance Level
- SMX $0.29
- ABVC $0.59
- Average True Range (ATR)
- SMX 0.03
- ABVC 0.05
- MACD
- SMX 0.09
- ABVC 0.00
- Stochastic Oscillator
- SMX 22.10
- ABVC 38.16
About SMX SMX (Security Matters) Public Limited Company
SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.